Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by HAGOP M KANTARJIAN and RONALD S WALTERS.
HAGOP M KANTARJIAN
Connection Strength
0.570
RONALD S WALTERS
  1. Implications of cytogenetic findings in secondary leukemia. Am J Clin Oncol. 1987 Oct; 10(5):453-6.
    View in: PubMed
    Score: 0.079
  2. The importance of cytogenetic studies in adult acute lymphocytic leukemia. Am J Med. 1990 Nov; 89(5):579-87.
    View in: PubMed
    Score: 0.025
  3. Mitoxantrone and high-dose cytosine arabinoside for the treatment of refractory acute lymphocytic leukemia. Cancer. 1990 Jan 01; 65(1):5-8.
    View in: PubMed
    Score: 0.023
  4. Experience with vincristine, doxorubicin, and dexamethasone (VAD) chemotherapy in adults with refractory acute lymphocytic leukemia. Cancer. 1989 Jul 01; 64(1):16-22.
    View in: PubMed
    Score: 0.022
  5. Phase II study of low-dose continuous infusion homoharringtonine in refractory acute myelogenous leukemia. Cancer. 1989 Mar 01; 63(5):813-7.
    View in: PubMed
    Score: 0.022
  6. Identification of risk groups for development of central nervous system leukemia in adults with acute lymphocytic leukemia. Blood. 1988 Nov; 72(5):1784-9.
    View in: PubMed
    Score: 0.021
  7. Treatment of the blastic phase of chronic myelogenous leukemia with mitoxantrone and high-dose cytosine arabinoside. Cancer. 1988 Aug 15; 62(4):672-6.
    View in: PubMed
    Score: 0.021
  8. Mitoxantrone and high-dose cytosine arabinoside in refractory acute myelogenous leukemia. Cancer. 1988 Aug 15; 62(4):677-82.
    View in: PubMed
    Score: 0.021
  9. Characteristics of accelerated disease in chronic myelogenous leukemia. Cancer. 1988 Apr 01; 61(7):1441-6.
    View in: PubMed
    Score: 0.021
  10. The characteristics and outcome of patients with late relapse acute myelogenous leukemia. J Clin Oncol. 1988 Feb; 6(2):232-8.
    View in: PubMed
    Score: 0.020
  11. Therapy of lymphoid and undifferentiated chronic myelogenous leukemia in blast crisis with continuous vincristine and adriamycin infusions plus high-dose decadron. Cancer. 1987 Oct 15; 60(8):1708-12.
    View in: PubMed
    Score: 0.020
  12. Old age: a sign of poor prognosis in patients with chronic myelogenous leukemia. South Med J. 1987 Oct; 80(10):1228-32.
    View in: PubMed
    Score: 0.020
  13. Chronic myelogenous leukemia in blast crisis. Analysis of 242 patients. Am J Med. 1987 Sep; 83(3):445-54.
    View in: PubMed
    Score: 0.020
  14. Intensive treatment of acute leukemia in adults 70 years of age and older. Cancer. 1987 Jul 15; 60(2):149-55.
    View in: PubMed
    Score: 0.020
  15. Role of maintenance chemotherapy in acute promyelocytic leukemia. Cancer. 1987 Apr 01; 59(7):1258-63.
    View in: PubMed
    Score: 0.019
  16. Therapy-related leukemia and myelodysplastic syndrome: clinical, cytogenetic, and prognostic features. J Clin Oncol. 1986 Dec; 4(12):1748-57.
    View in: PubMed
    Score: 0.019
  17. Clinical and prognostic features of Philadelphia chromosome-negative chronic myelogenous leukemia. Cancer. 1986 Nov 01; 58(9):2023-30.
    View in: PubMed
    Score: 0.019
  18. Early intensification and short-term maintenance chemotherapy does not prolong survival in acute myelogenous leukemia. Cancer. 1986 Oct 15; 58(8):1603-8.
    View in: PubMed
    Score: 0.019
  19. Phase I-II clinical and pharmacologic studies of high-dose cytosine arabinoside in refractory leukemia. Am J Med. 1986 Sep; 81(3):387-94.
    View in: PubMed
    Score: 0.018
  20. The association of specific "favorable" cytogenetic abnormalities with secondary leukemia. Cancer. 1986 Aug 15; 58(4):924-7.
    View in: PubMed
    Score: 0.018
  21. Acute promyelocytic leukemia. M.D. Anderson Hospital experience. Am J Med. 1986 May; 80(5):789-97.
    View in: PubMed
    Score: 0.018
  22. Chronic myelogenous leukemia: a multivariate analysis of the associations of patient characteristics and therapy with survival. Blood. 1985 Dec; 66(6):1326-35.
    View in: PubMed
    Score: 0.017
  23. A characteristic pattern of leukemic cell differentiation without cytoreduction during remission induction in acute promyelocytic leukemia. J Clin Oncol. 1985 Jun; 3(6):793-8.
    View in: PubMed
    Score: 0.017
  24. A comparison of marrow transplantation with chemotherapy for adults with acute leukemia of poor prognosis in first complete remission. J Clin Oncol. 1988 Oct; 6(10):1548-57.
    View in: PubMed
    Score: 0.011
  25. Response to salvage therapy and survival after relapse in acute myelogenous leukemia. J Clin Oncol. 1989 Aug; 7(8):1071-80.
    View in: PubMed
    Score: 0.006
  26. Detection of leukemic clone maturation in vivo by premature chromosome condensation. Blood. 1988 Dec; 72(6):1950-60.
    View in: PubMed
    Score: 0.005
  27. Cytogenetic pattern in acute myelogenous leukemia: a major reproducible determinant of outcome. Leukemia. 1988 Jul; 2(7):403-12.
    View in: PubMed
    Score: 0.005
  28. Rebound peripheral blastosis with subsequent remission during remission induction in a patient with acute promyelocytic leukemia. Cancer. 1988 Feb 15; 61(4):650-3.
    View in: PubMed
    Score: 0.005
  29. Therapy of chronic myelogenous leukemia with recombinant interferon-gamma. Blood. 1987 Oct; 70(4):943-7.
    View in: PubMed
    Score: 0.005
  30. A strategy for evaluation of new treatments in untreated patients: application to a clinical trial of AMSA for acute leukemia. J Clin Oncol. 1987 May; 5(5):710-21.
    View in: PubMed
    Score: 0.005
  31. Comparison of results of salvage therapy in adult acute myelogenous leukemia. Acta Haematol. 1987; 78 Suppl 1:120-6.
    View in: PubMed
    Score: 0.005
  32. Evolution of clinical studies with high-dose cytosine arabinoside at the M.D. Anderson Hospital. Semin Oncol. 1985 Jun; 12(2 Suppl 3):98-104.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.